Public Use of Daily Baby Aspirin Plummets by 57 Percent Following Major Shifts in Clinical Guidelines

Discover why cardiologists are moving away from daily baby aspirin for heart health, as use drops 57% due to bleeding risks and updated medical guidelines.

By: AXL Media

Published: Apr 26, 2026, 7:44 AM EDT

Source: Information for this report was sourced from Yahoo News

The Dramatic Decline of a Decades-Old Habit

For nearly half a century, the daily "baby" aspirin was a staple in the medicine cabinets of older adults seeking to ward off heart attacks and strokes. However, according to an analysis of 279 million primary care visits by Epic Research, this common practice has fallen out of favor, dropping by 57% between 2018 and the end of 2025. Cardiologists, including Dr. Kevin Shah of the MemorialCare Heart & Vascular Institute, explain that while the medication makes blood platelets less sticky to prevent artery blockages, more recent scientific data has fundamentally changed the risk-benefit analysis for the general population.

Updated Guidelines From Major Health Organizations

The shift in public behavior is a direct result of a series of high-profile changes to clinical guidelines. In 2016, the U.S. Preventive Services Task Force (USPSTF) assigned a "B" grade to aspirin for certain high-risk adults, but by 2019, the American Heart Association (AHA) and the American College of Cardiology (ACC) began recommending against aspirin as a primary prevention tool. The final blow to the practice came in 2022, when the USPSTF formally recommended that adults aged 60 and older avoid starting a daily aspirin regimen entirely. These changes reflect a growing consensus that the preventative benefits are often outweighed by the danger of gastrointestinal and internal bleeding.

The Rise of Alternative Preventative Strategies

One of the primary reasons for the departure from aspirin is the advancement in other cardiovascular treatments. Dr. Corey Bradley of New York-Presbyterian/Columbia University notes that the medical community's ability to address high cholesterol and hypertension has improved significantly. The data now suggests that focusing on blood pressure medication and statins is not only more effective at preventing heart disease but is also considerably safer than long-term aspirin use. As these safer alternatives became the standard of care, the marginal benefit of aspirin for otherwise healthy individuals became harder to justify.